Description

BSE announces revocation of suspension in trading of equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373).

Summary

BSE has revoked the suspension in trading of equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373, ISIN: INE795B01031). The company is a manufacturer and dealer of citric acid, registered in Mumbai with its plant located in Rishikesh, Uttarakhand. The company profile indicates active operational status and listing only on BSE Limited.

Key Points

  • Trading suspension revoked for Citurgia Biochemicals Limited
  • Scrip Code: 506373
  • ISIN: INE795B01031
  • Company is engaged in manufacturing, processing, refining, and dealing in citric acid
  • Registered office: Mumbai-400065, Maharashtra
  • Plant location: Virbhadra Road, Rishikesh, Uttarakhand – 249201
  • Listed only on BSE Limited
  • Current auditors: G.P. Keshri & Associates (appointed for FY 2022-2027)
  • Company is in process of appointing Company Secretary & Compliance Officer

Regulatory Changes

The suspension previously imposed on trading of equity shares of Citurgia Biochemicals Limited has been revoked by BSE, allowing normal trading to resume.

Compliance Requirements

  • The company has paid listing fees to BSE
  • Company profile disclosure submitted as per Annexure IV requirements
  • Company needs to complete appointment of Company Secretary & Compliance Officer

Important Dates

  • Circular Date: January 30, 2026
  • Company Profile Date: November 7, 2025
  • Auditor Appointment Period: April 1, 2022 to March 31, 2027

Impact Assessment

The revocation of trading suspension has high impact on the stock as it restores normal trading activity. Investors can now buy and sell shares of Citurgia Biochemicals Limited on BSE. This improves liquidity and market access for the security. The company has operational business in citric acid manufacturing with active status, though it is in the process of appointing key compliance personnel.

Impact Justification

Revocation of trading suspension directly impacts trading activity and liquidity for the specific security, allowing resumed trading for investors.